Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Performance enhancers

This article was originally published in The Tan Sheet

Executive Summary

"It would be inappropriate and illegal for any manufacturer of any nutritional supplement to include any unlabeled ingredient, including nandrolone," CRN says Sept. 27, responding to allegations made at the Summer Olympics about mislabeled supplements. U.S. shot putter C.J. Hunter, who did not compete in Sydney, stated his positive drug tests earlier this summer may have resulted from use of nutritional supplements. Nandrolone is an anabolic steroid banned by the International Olympic Committee. Performance-enhancing drugs are the primary focus of the newly established White House Task Force on Drug Use in Sports, formed in August and expected to release a preliminary report early next year (1"The Tan Sheet" Aug. 21, p. 3)

You may also be interested in...



Nandrolone in the U.K.

Medicines Control Agency notifying 20 manufacturers of supplements containing nandrolone precursors that such products must be licensed under the Medicines Act. Manufacturers will be obligated to stop selling products in nonprescription settings immediately upon receipt of MCA's letter. The action, which affects about 50 products, is taken following MCA's investigation of a complaint about such supplements. Issues involving nandrolone and nandrolone precursors in supplements also arose during the 2000 Sydney Olympics (1"The Tan Sheet" Oct. 2, 2000, In Brief)

Nandrolone in the U.K.

Medicines Control Agency notifying 20 manufacturers of supplements containing nandrolone precursors that such products must be licensed under the Medicines Act. Manufacturers will be obligated to stop selling products in nonprescription settings immediately upon receipt of MCA's letter. The action, which affects about 50 products, is taken following MCA's investigation of a complaint about such supplements. Issues involving nandrolone and nandrolone precursors in supplements also arose during the 2000 Sydney Olympics (1"The Tan Sheet" Oct. 2, 2000, In Brief)

Nandrolone in the U.K.

Medicines Control Agency notifying 20 manufacturers of supplements containing nandrolone precursors that such products must be licensed under the Medicines Act. Manufacturers will be obligated to stop selling products in nonprescription settings immediately upon receipt of MCA's letter. The action, which affects about 50 products, is taken following MCA's investigation of a complaint about such supplements. Issues involving nandrolone and nandrolone precursors in supplements also arose during the 2000 Sydney Olympics (1"The Tan Sheet" Oct. 2, 2000, In Brief)

Topics

UsernamePublicRestriction

Register

ID1128360

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel